Nabi Biopharma’s latest biotech-stock casualty By: MarketWatch July 27, 2011 at 13:33 PM EDT Analysts don’t expect shares of the company, which has had much riding on a smoking-cessation product in development, to rebound any time soon. Read More >> Related Stocks: Gsk Plc ADR